RAFFA WEALTH MANAGEMENT, LLC’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
EAM
CUAMC
PFSRSONJ
TWM
IAIM
DIM
IFG
AHL
RAFFA WEALTH MANAGEMENT, LLC's EDIT Position: Q2 2026 in Review
RAFFA WEALTH MANAGEMENT, LLC held its Editas Medicine (EDIT) position steady in Q2 2026 at 19 shares worth $62. The position accounts for ﹤0.01% of the portfolio, ranked #1483.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in EDIT in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.37K in Q4 2020. 46 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC held 19 shares of Editas Medicine worth $62 as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC left its Editas Medicine share count unchanged in Q2 2026.
- Editas Medicine made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #1483 holding.
- RAFFA WEALTH MANAGEMENT, LLC first reported a position in Editas Medicine in Q4 2020 and has held it in 23 quarters since.
- RAFFA WEALTH MANAGEMENT, LLC's Editas Medicine position peaked at $3.37K in Q4 2020.
- 46 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.
Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.